Ayurvedic Treatment for Anemia in Pregnancy

COMPARATIVE STUDY OF PHALATRIKADI GHANVATI AND NAVAYAS LAUHA VATI IN MANAGEMENT OF GARBHINI PANDU

Status

Recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/03/008211

Enrollment

Registered

2017-03-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- 1. Primi and multi gravida. 2. Hb% between 8 to 10 gm% 3.Patient in between 16 to 24weeks of gestational age.

Interventions

Intervention1: PHALATRIKADI GHANA VATI: Ref. Tripathi B., Sharangdhar samhita, edition year 2012, Varanasi, Chaukhmbha publication madhyama khanda,p-144,(verse-75). Dose - 2 TID Route of administratio

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient will be selected irrespective of their age, social, economic status, and education. 2. Primi and multi gravida. 3. Hb% between 8 to 10 gm% 4. Patient in between 16 to 24weeks of gestational age. 5.Those patient who ready to sign the inform consent form will be included only

Exclusion criteria

Exclusion criteria: 1. Hb % less than 8 gm% 2. Aneamia due to other pathology like bleeding piles. 3. Any other associated obstreticle complication like pre-eclampsia, gestational diabetes. 4. Systemic disease like Diabetes mellitus, Hypertension, Sickle cell anaemia.

Design outcomes

Primary

Measure	Time frame
1. Changes of Hb gm% 2. Improvement of sign like Panduvarna of Twak,Netra,Nakha,Jihva & symptoms like Daurbalya, Shwasa, Bhrama, Ann, Aruchi, Gatra Shoola. 3. For subjective and objective parameters suitable scoring pattern will be developed. 4. The final effect will be assessed in terms of no improvement, mild improvement, moderate improvement and remarkable improvement.Timepoint: After completion of therapy - 90days	—

Measure

Time frame

1. Changes of Hb gm% 2. Improvement of sign like Panduvarna of Twak,Netra,Nakha,Jihva & symptoms like Daurbalya, Shwasa, Bhrama, Ann, Aruchi, Gatra Shoola. 3. For subjective and objective parameters suitable scoring pattern will be developed. 4. The final effect will be assessed in terms of no improvement, mild improvement, moderate improvement and remarkable improvement.Timepoint: After completion of therapy - 90days

—

Secondary

Measure	Time frame
The total effect of the therapy will be assessed considering to the overall improvement in signs and symptoms. For this purpose, following categories will be maintained 1. Complete remission: 76%-100% relief in the signs and symptoms will be considered as complete remission. 2. Marked improvement: 51%- 75% relief in the signs and symptoms. 3. Improved: 26%-50 % relief 4. Unchanged: Below 25% reliefTimepoint: Every 15 days till completion of therapy. After completion of therapy every 15days for 2 months	—

Measure

Time frame

The total effect of the therapy will be assessed considering to the overall improvement in signs and symptoms. For this purpose, following categories will be maintained 1. Complete remission: 76%-100% relief in the signs and symptoms will be considered as complete remission. 2. Marked improvement: 51%- 75% relief in the signs and symptoms. 3. Improved: 26%-50 % relief 4. Unchanged: Below 25% reliefTimepoint: Every 15 days till completion of therapy. After completion of therapy every 15days for 2 months

—

Countries

India

Contacts

Public ContactTrupti Danidhariya

parul institute of ayurved

ritamakim@gmail.com9427538404

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026